0001650139-15-000002.txt : 20150819 0001650139-15-000002.hdr.sgml : 20150819 20150819163836 ACCESSION NUMBER: 0001650139-15-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150819 DATE AS OF CHANGE: 20150819 EFFECTIVENESS DATE: 20150819 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Turing Pharmaceuticals AG CENTRAL INDEX KEY: 0001650139 IRS NUMBER: 000000000 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-245166 FILM NUMBER: 151064464 BUSINESS ADDRESS: STREET 1: 1177 AVENUE OF THE AMERICAS STREET 2: 39TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: (646) 356-5560 MAIL ADDRESS: STREET 1: 1177 AVENUE OF THE AMERICAS STREET 2: 39TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 D/A 1 primary_doc.xml X0707 D/A LIVE 0001650139 Turing Pharmaceuticals AG Haldenstrasse 5 Baar V8 SWITZERLAND CH-6340 (646) 356-5577 SWITZERLAND None None Corporation true 2014 Martin Shkreli 1177 Avenue of the Americas 39th floor New York NY NEW YORK 10036 Executive Officer Director Ron Tilles 1177 Avenue of the Americas 39th floor NEW YORK NY NEW YORK 10036 Director Alan Geller 1177 Avenue of the Americas 39th floor New York NY NEW YORK 10036 Director Walter Blum Haldenstrasse 5 Postfach 1359 Baar V8 SWITZERLAND 6341 Director Michael Harrison 1177 Avenue of the Americas 39th floor NEW YORK NY NEW YORK 10036 Executive Officer Pharmaceuticals Decline to Disclose 06b true 0001650139-15-000001 2015-07-23 false true true true Offering Amount includes senior secured term loan false 25000 Indefinite 90277685 Indefinite false 43 0 0 0 false Turing Pharmaceuticals AG Michael Harrison Michael Harrison Chief Financial Officer 2015-08-19